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[Abstract] Protein aggregation is a hallmark of several neurodegenerative diseases and is associated 
with impaired protein homeostasis. This imbalance is caused by the loss of the protein’s native 
conformation, which ultimately results in its aggregation or abnormal localization within the cell. Using a 
C. elegans model of polyglutamine diseases, we describe in detail the filter retardation assay, a method 
that captures protein aggregates in a cellulose acetate membrane and allows its detection and 
quantification by immunoblotting. 
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[Background] One pathological feature of neurodegenerative diseases like Parkinson’s, Alzheimer’s 
and polyglutamine diseases is the presence of protein aggregates in distinct areas of the brain 
(reviewed in Soto, 2003; Stroo et al., 2017). In the case of polyglutamine diseases, abnormal 
expansion of glutamine (CAG) repeats in the coding sequence disturbs the native folding of the protein. 
As a result, the misfolded protein exposes regions of its amino acid sequence, which makes it prone to 
aggregate with other proteins, forming large, insoluble aggregates that can hamper normal cellular 
function (reviewed in Kuiper et al., 2017). 
  Several methods have been developed for the detection of insoluble protein aggregates including, for 
instance, dye binding assays (e.g., Thioflavin T, Congo red, NIAD-4) and electron microscopy. Filter 
retardation assay is a quick and sensitive method that detects and quantifies protein aggregates 
formed in vivo and in vitro, including polyglutamine (Scherzinger et al., 1997; Wanker et al., 1999), 
alpha-synuclein (Recasens et al., 2018), and amyloid-beta aggregates (Bieschke et al., 2009). In this 
assay, sodium dodecyl sulfate (SDS)-resistant protein aggregates are filtered and retained in a 
cellulose acetate membrane, while monomeric intermediate species are not captured. The protein 
aggregates retained in the membrane are subsequently detected by antibodies, which allows for their 
quantification. 
  This protocol describes a method to detect and quantify SDS-resistant polyglutamine aggregates in 
the nematode Caenorhabditis elegans and can be applied to investigate the aggregation of 
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aggregation-prone proteins in vivo and in vitro. 
 
Materials and Reagents 
 
1. 200 µl pipette tips (Greiner Bio-one, catalog number: 741065) 
2. 1000 µl pipette tips (Greiner Bio-one, catalog number: 741045) 
3. 15 ml conical tubes (SARSTEDT, catalog number: 62.554.502) 
4. 2 ml Screw cap tubes (SARSTEDT, catalog number: 72.693.105) 
5. 0.5 mm Glass beads (Carl Roth, catalog number: N030.1) 
6. 11.3 x 7.7 cm Bio-Dot/Bio-Dot SF Filter Paper (Bio-Rad Laboratories, catalog number: 
1620161) 
7. Cellulose acetate membranes, 0.22 micron, Sphaero (Sterlitech, catalog number: CA023001) 
8. 1.5 ml microfuge tube (Greiner Bio One International, catalog number: 616201) 
9. Rubber seal 
10. Plastic wrap 
11. 50 ml conical tube (SARSTEDT, catalog number: 62.547.004) 
12. Worms 
13. PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific, catalog number: 23227) 
14. Complete protease inhibitors (Roche Diagnostics, catalog number: 11697498001) 
15. ECLTM Prime Western Blotting Detection (GE Healthcare, Amersham, catalog number: 
RPN2232) 
16. Liquid nitrogen 
17. Triton X-100 (Sigma-Aldrich, catalog number: T8787) 
18. DL-Dithiothreitol (DTT) (Sigma-Aldrich, catalog number: D0632) 
19. 1 M Tris-HCl 
20. 5 M NaCl 
21. 10% SDS 
22. Milli-Q water 
23. Non-fat dry milk powder (Campina) 
24. Antibodies against green fluorescent protein (GFP)/yellow fluorescent protein (YFP) and 
tubulin (Table 1) 
 
Table 1. List of primary and secondary antibodies 
Primary 
antibody 
Host Company/catalog number 
Dilution primary 
antibody 
Secondary antibody 
α-GFP Mouse 
TaKaRa Bio, Clontech Laboratories 
(632381) 
1:5,000 
Anti-mouse (1:10,000)  
Bio-Rad (1706516) 
α-tubulin Mouse Sigma-Aldrich (T6074) 1:5,000 
Anti-mouse (1:10,000) 
Bio-Rad (1706516) 
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25. Sodium phosphate dibasic heptahydrate (Na2HPO4·7H2O) (Acros Organics, catalog number: 
424380010) 
26. Sodium chloride (NaCl) (Merck, catalog number: 1064041000) 
27. Potassium chloride (KCl) (Fisher Chemicals, catalog number: 10010310) 
28. 10x Phosphate buffered saline (PBS) (see Recipes) 
29. 1x PBS-Triton 0.1% (see Recipes) 
30. 1x PBS-Triton 0.05% (see Recipes) 
31. Filter trap assay (FTA) sample buffer (see Recipes) 
32. FTA wash buffer (see Recipes) 
33. 1 M dithiothreitol (DTT, see Recipes) 
34. Blocking solution (see Recipes) 
 
Equipment 
 
1. P20 Pipetman (Gilson, catalog number: F123600) 
2. P200 Pipetman (Gilson, catalog number: F123601) 
3. P1000 Pipetman (Gilson, catalog number: F123602) 
4. 30-300 μl multi-channel pipette (Eppendorf, catalog number: 3125000052) 
5. 10 ml Serological glass pipettes (SARSTEDT, catalog number: 86.1254.001) 
6. Centrifuge (Thermo Fisher Scientific, model: SL 40R, rotor: TX-750) 
7. Bead beater (MP Biomedicals, model: FastPrep-24) 
8. 48-well Bio-Dot Microfiltration System (Bio-Rad Laboratories, catalog number: 1703938) 
9. Vacuum pump  
10. 20 °C incubator (LIEBHERR, model: WK 4126) 
11. Vortex (Fisher scientific, model: ZX Wizard vortex, catalog number: 11746744) 
12. Fuji Super RX-N 13x18 film (Fujifilm, catalog number: RX1318) 
13. Autoclave 
 
Software 
 
1. ImageJ (Open source: https://imagej.nih.gov/ij/) 
2. Microsoft Excel (Microsoft Corporation, Redmond, USA) 
 
Procedure 
 
A. Sample preparation 
1. Prepare 10-15 plates with approximately 800-1,000 synchronized L4 worms per 9 cm NGM 
plate. 
2. Wash worms off from plates with 8-10 ml 1x PBS using a 10 ml serological glass pipette and 
collect worms into a 15 ml conical tube. 
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3. Centrifuge worms at 1,000 x g for 2 min at room temperature. Discard supernatant without 
disturbing the worm pellet. 
4. Repeat Step A2 (washing with 1x PBS) a total of three times or until supernatant is clear. 
Remove supernatant and leave 1.5-2.0 ml (or just enough volume to cover the worm pellet). 
5. Pre-wet a P1000 blue tip by pipetting PBS with 0.05% Triton X-100 “up-and-down”. This helps 
to decrease worms sticking to the wall of the plastic tip. 
6. Use this P1000 blue tip and transfer worms to one 2 ml screw cap tube and briefly centrifuge at 
1,000 x g for 2 min to sediment the worms. Discard supernatant. 
7. Wash worms once with cold 500 μl FTA wash buffer. 
8. Add cold FTA sample buffer to the worm pellet in a 1:1 ratio (e.g., 10-15 plates yield about 250 
μl of worm pellet). 
9. Add 0.5 mm glass beads in a 2:1 ratio by volume. 
10. Bead beat samples for 7 cycles of 20 sec at 4 m/sec with 5 min rest in between cycles. Keep 
the samples on ice whenever possible.  
Note: This protocol is performed using a bead beater at room temperature. Therefore, it is 
important to keep the samples on ice whenever possible (e.g., in between the 5 min rest 
cycles). 
11. Transfer supernatant to a 1.5 ml microfuge tube. 
Safe stopping point: Flash freeze samples in liquid nitrogen and store at -80 °C until further 
use. 
12. Measure protein concentration by using the PierceTM BCA Protein Assay Kit. 
Note: For 10-15 plates of synchronized L4 worms, we find that the protein yield varies between 
2-5 mg/ml. This variability will depend on factors such as the efficiency of the worm 
synchronization by bleaching (therefore the number of worms per plate to start with), how well 
the worms were washed off of the plates and transferred to microfuge tubes, etc. 
13. Transfer 100 μg of total protein to a 1.5 ml microfuge tube and add cold FTA sample buffer to a 
final volume of 400 μl (final concentration 100 μg/400 μl). For loading control, take 1-5 μg of 
sample to run separately by a 10 or 12% SDS–polyacrylamide gel electrophoresis 
(SDS-PAGE). 
14. Add 20 μl 1 M DTT. 
15. Boil samples at 98 °C for 5 min. 
16. Prepare two dilutions for each sample in new 1.5 ml microfuge tubes: 
Dilution Sample (μl) FTA sample buffer (μl) Total volume (μl) 
5x 40 160 200 
25x 8 192 200 
 
B. Setting up the Bio-Dot microfiltration system 
1. Soak two 11.3 x 7.7 cm Bio-Dot/Bio-Dot SF filter papers and one cellulose acetate membrane 
(cut to similar size) in about 25 ml of FTA wash buffer. 
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2. Place these on the base of the Bio-Dot Microfiltration System, with the cellulose acetate 
membrane on top of the filter papers. 
3. Roll out any air bubbles using a glass pipette. 
4. Place the rubber seal and lid onto the Bio-Dot Microfiltration System, insert and tighten all four 
screws diagonally so the pressure is evenly spread (Figure 1).  
 
Figure 1. Bio-Dot Microfiltration System with rubber seal and diagonal tightening of the 
screws  
5. Apply vacuum and tighten the screws further. Turn off the vacuum. 
6. Using a multi-channel pipette, wash each well of the Bio-Dot Microfiltration System with 100 μl 
FTA wash buffer and apply full vacuum until the wells are empty. 
7. Repeat this step a total of three times. 
8. While the vacuum is turned off, turn the T-shaped connector 180° and place a P1000 blue tip 
on it to apply low vacuum (Figure 2). 
 
 
Figure 2. Schematic representation of how to set up the Bio-Dot Microfiltration System 
to low vacuum  
9. Load 100 μl of the undiluted, 5-fold and 25-fold diluted samples to adjacent wells while placing 
the pipette tip to the side of the well to avoid air bubbles. 
10. Apply low vacuum until the wells are empty (should take about 2 to 3 min). 
11. Wash the wells three times each with 100 μl FTA wash buffer. 
12. Dismantle the apparatus and clean it properly with demineralized water. 
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C. Immunodetection of protein aggregates on cellulose acetate membrane 
1. Apply 15 ml of blocking solution (5% milk in 1x PBS-Triton 0.1%) per membrane and incubate 
at room temperature for 30 min. 
2. Remove blocking solution, then apply 15 ml of primary antibody diluted in blocking solution 
(see Table 1 for dilution). Incubate at 4 °C overnight. 
3. Wash the membranes three times for 5 min in PBS-Triton 0.1%. 
4. Apply 15 ml of secondary antibody diluted in blocking solution (see Table 1) and incubate at 
room temperature for 1 h. 
5. Wash the membranes three times for 5 min in PBS-Triton 0.1%. 
6. Place the membranes in a plastic wrap and apply 1 ml of ECLTM Prime Western Blotting 
Detection Reagent per membrane. Incubate for 1 min. 
7. Remove excess liquid and air bubbles and develop. 
 
Data analysis 
 
In Sin et al. (2017), a forward genetic screen was performed on worms that express 40 glutamine 
(Q) repeats fused to YFP (here referred as Q40 worms) to search for mutants with reduced number 
of polyglutamine aggregates (Sin et al., 2017) (Figure 3A). The study identified a regulator of RNA 
polymerase III transcription–moag-2/lir-3–as an aggregation-promoting factor. The inactivation of 
this gene (by point mutation or deletion of the allele) reduced polyglutamine aggregation (Figure 3).  
  At least three independent experiments should be performed and alternative options for equal 
protein loading controls can be used (e.g., actin). If using a fluorescent reporter gene to monitor 
protein aggregation (e.g., GFP, mCherry), one should quantify its expression levels to exclude the 
possibility that the effects observed are due to changes in the expression level of the reporter gene. 
  Immunoblots were quantified by densitometry using ImageJ. An example of data analysis can be 
found in Figure 1F and S1E of Sin et al. (2017). To quantify the relative amount of SDS-insoluble 
protein, a ratio (fold change) was calculated by dividing the values of Q40; moag-2/lir-3 mutants 
(undiluted sample of the point-mutation allele pk2183 and deletion allele tm813 shown on Figure 
3B, top) by their corresponding wild-types (wt, previously normalized to α-tubulin as a loading 
control). In this study, Q40-YFP and α-tubulin expression were included as controls (Figure 3B, 
bottom). A more detailed tutorial is also available at 
https://imagej.nih.gov/ij/docs/menus/analyze.html (under “Gels Submenu”) and at 
http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-blots-with-image-j/. 
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Figure 3. Filter retardation assay with 5- and 25-fold dilutions of crude protein lysate 
from Q40 worms and Q40; moag-2/lir-3 mutant worms (point-mutation allele pk2183 and 
deletion allele tm813). A. Representative image of a Q40 worm (strain AM141) and a Q40; 
moag-2/lir-3 (pk2183) worm (Sin et al., 2017). Scale bar = 75 µm. B. On top, a representative 
immunoblot which was probed with α-GFP antibody to detect polyglutamine aggregates. On 
the bottom, an input control is shown by standard Western immunoblot analysis of worm 
lysates probed with α-GFP (control for YFP expression) and α-tubulin (control for equal protein 
loading) antibodies. C. Quantification of filter retardation assays by densitometry using ImageJ. 
The average of three biological replicates is represented. Data are represented as mean ± 
SEM and significance was calculated using a one-tailed unpaired Student’s t-test. *P < 0.05. 
More details of the experiment can be found in Sin et al. (2017). 
 
Recipes 
 
1. 10x PBS (1 L) 
a. Mix 25.6 g Na2HPO4·7H2O, 80 g NaCl, 2 g KCl, 2 g KH2PO4 
b. Bring to 1 L with distilled water 
c. Autoclave for 20 min at 121 °C 
d. 10x PBS is kept at room temperature 
e. Dilute to 1x with distilled water, and adjust pH to 7.0 for working solution 
f. The 1x PBS can be kept at room temperature  
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2. 1x PBS with 0.1% Triton X-100 (10 ml) 
Add 1 ml of Triton X-100 to 10 ml of 1x PBS and mix 
3. 1x PBS with 0.05% Triton X-100 (10 ml) 
Add 500 μl of Triton X-100 to 10 ml of 1x PBS and mix 
4. Filter Trap Assay (FTA) sample buffer (50 ml, make fresh prior to use) 
a. Add all of the components: 
500 μl of 1 M Tris-HCl pH 8.0 (final concentration: 10 mM) 
1.5 ml of 5 M NaCl (final concentration: 150 mM) 
10 ml of 10% SDS (final concentration: 2%) 
Add Complete protease inhibitors (1 tablet per 10 ml) 
b. Fill up to 50 ml with Milli-Q water 
5. Filter Trap Assay (FTA) wash buffer (50 ml, make fresh prior to use) 
a. Add all of the components: 
500 μl of 1 M Tris-HCl pH 8.0 (final concentration: 10 mM) 
1.5 ml of 5 M NaCl (final concentration: 150 mM) 
500 μl of 10% SDS (final concentration: 0.1%) 
Add Complete protease inhibitors (1 tablet per 10 ml) 
b. Fill up to 50 ml with Milli-Q water 
6. 1 M dithiothreitol (DTT) (10 ml) 
a. Dissolve 1.5 g of DTT (MW = 154.25) in 8 ml of deionized or distilled water 
b. Adjust volume to 10 ml and make 1 ml aliquots 
c. Store at -20 °C (for long-term) 
7. Blocking solution (5% milk in 1x PBS-Triton 0.1%) (50 ml, make fresh prior to use) 
a. Weigh 2.5 g of non-fat dry milk powder into a 50 ml conical tube and add up to 50 ml of 
PBS-Triton 0.1% 
b. Vortex to mix thoroughly 
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